Evox Therapeutics

Evox Therapeutics is a privately held biotechnology company based in Oxford that focuses on enhancing the natural delivery capabilities of exosomes and developing entirely new therapies. Backed by leading venture capital groups and leveraging a comprehensive portfolio of proprietary intellectual property, Evox's mission is to positively impact human health by developing novel exosome-based therapies to treat rare and severe diseases, offering limited treatment options for patients and their families. Evox has developed an unparalleled proprietary technology platform, DeliverEX™, enabling it to modify exosomes, load drugs into exosomes, and target the delivery of these exosomes to specific organs. Evox has successfully demonstrated this capability by delivering drug-loaded exosomes to target organs, including the central nervous system and other hard-to-reach tissues. Exosome-based therapeutics hold the potential to address certain limitations of protein-, antibody-, and nucleic acid-based therapies by reaching cells and tissues currently inaccessible through other drug delivery technologies. Evox is at the forefront of this emerging field and is poised to pioneer new frontiers in treating severe rare genetic disorders with its innovative exosome therapies.